Brain Diseases: Clinical Trials

2,646 trials for Brain Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2646 completed. 2646 Phase 2, 428 Phase 1, 221 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22646Completed 2646
Phase 1428Completed 428
Phase 3221Completed 221

Follow Brain Diseases: new trials by email Literature Review of Brain Diseases trials Research Report on Brain Diseases

Trials (filtered) newest first · largest first

All 2,646 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fisetin in Mild Alzheimer's Disease
Fisetin - Alzheimer s Disease, Alzheimer Dementia
Phase 2CompletedSunnybrook Health Sciences Centre52026-01-272026-08-20
CAROTID STABILISE Pilot: Alirocumab for Symptomatic Carotid Stenosis
Alirocumab, Matching placebo - Carotid Artery Stenosis
Phase 2CompletedMiddle East North Africa Stroke and Interventional Neurotherapies Organization402026-01-062026-11-16
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
HRS-7450 Injection, HRS-7450 Injection Placebo - Acute Ischemic Stroke
Phase 2CompletedFujian Shengdi Pharmaceutical Co., Ltd.2102025-10-312026-10-20
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
Ivolumab 420mg (three vials) - Acute Stroke
Phase 2CompletedThe Affiliated Hospital of Xuzhou Medical University1322025-10-302026-09-10
Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)
A-DOPAMINE - Parkinson Disease
Phase 1 / Phase 2CompletedUniversity Hospital, Lille12025-10-012026-05-22
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
MT200605, Placebo - Acute Ischemic Stroke
Phase 2CompletedShaanxi Micot Pharmaceutical Technology Co., Ltd.3602025-09-302026-11-12
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
aspirin + clopidogrel, Aspirin - Acute Ischemic Stroke
Phase 2CompletedUniversity of Alberta32025-09-022026-07-16
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
JNT-517 Tablet, Placebo - Phenylketonuria (PKU)
Phase 2CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.142025-07-162026-05-13
Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride
New TETA 4HCl Formulation, Standard of Care - Wilson's Disease
Phase 2CompletedOrphalan102025-07-152026-04-06
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
Placebo, ML-007C-MA BID, ML-007C-MA QD - Schizophrenia
Phase 2CompletedMapLight Therapeutics3072025-06-272026-07-09
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke
Neflamapimod, Placebo - Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke
Phase 2CompletedEIP Pharma Inc452025-06-202026-10-28
A Study to Assess TTI-0102 vs Placebo in MELAS Patients
TTI-0102, Placebo - MELAS Syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
Phase 2CompletedThiogenesis Therapeutics, Inc.92025-05-122026-07-24
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
levodopa-carbidopa, Silymarin - Parkinson Disease
Phase 2CompletedTanta University502025-05-102026-11-04
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
ONO-2020, Placebo - Alzheimer Disease
Phase 2CompletedOno Pharmaceutical Co., Ltd.2602025-04-242026-10-22
BCAAs in Concussion 2.0
BCAA, Placebo - Concussion, Brain, Concussion, Mild
Phase 2CompletedAkiva Cohen172025-04-012026-09-03
A Study of NE3107 in Early Parkinson's
NE3107, Placebo - Parkinsons Disease (PD)
Phase 2CompletedBioVie Inc.572025-03-262026-08-11
A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke
OTR4132, Placebo - Endovascular Thrombectomy, Ischemic Cerebrovascular Accident
Phase 2CompletedOrgan, Tissue, Regeneration, Repair and Replacement602025-03-142026-06-26
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
NPT 2042, Placebo - Epilepsy, Generalized, Epilepsy, Absence
Phase 2CompletedNeuroPro Therapeutics, Inc.142025-03-112026-09-28
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Elismetrep (K-304) 2 mg, Elismetrep (K-304) 5 mg, Elismetrep (K-304) 10 mg - Migraine
Phase 2CompletedTriGemX Bio, Inc.4312025-03-112026-11-16
A Study of NTRX-07 in Participants With Alzheimer's Disease
NTRX-07, Placebo - Alzheimer Disease, Mild Cognitive Impairment
Phase 2CompletedNeuroTherapia, Inc.482025-03-012026-10-29

Showing 20 of 2646. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (414)  ·  Brain Neoplasms (374)  ·  Parkinson Disease (362)  ·  Stroke (312)  ·  Glioblastoma (192)  ·  Ischemic Stroke (150)  ·  Epilepsy (131)  ·  Dementia (128)  ·  Gliosarcoma (123)  ·  Glioma (120)  ·  Migraine Disorders (110)  ·  Central Nervous System Neoplasms (109)  ·  Astrocytoma (102)  ·  Cognitive Dysfunction (102)  ·  Oligodendroglioma (80)

Broader conditions

Nervous System Diseases (2613)  ·  Central Nervous System Diseases (2603)  ·  Neurodegenerative Diseases (942)  ·  Pathological Conditions, Signs and Symptoms (650)  ·  Mental Disorders (627)  ·  Cardiovascular Diseases (586)  ·  Vascular Diseases (583)  ·  Neurocognitive Disorders (555)  ·  Cerebrovascular Disorders (540)  ·  Basal Ganglia Diseases (486)  ·  Movement Disorders (466)  ·  Tauopathies (419)  ·  Dementia (418)  ·  Neoplasms (411)

Interventions

Temozolomide (63)  ·  Bevacizumab (49)  ·  Sodium Chloride (41)  ·  Saline Solution (35)  ·  Radiotherapy (30)  ·  Donepezil (27)  ·  Levodopa (25)  ·  Transcranial Direct Current Stimulation (23)  ·  Irinotecan (22)  ·  Aspirin (20)  ·  Levetiracetam (19)  ·  carbidopa, levodopa drug combination (19)  ·  Botulinum Toxins, Type A (18)  ·  Cyclophosphamide (18)  ·  Carboplatin (17)

Sponsors

National Cancer Institute (NCI) (51)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (45)  ·  Duke University (39)  ·  Pfizer (35)  ·  Novartis Pharmaceuticals (27)  ·  Eli Lilly and Company (23)  ·  Assistance Publique - Hôpitaux de Paris (19)  ·  US Department of Veterans Affairs (18)  ·  Genzyme, a Sanofi Company (17)  ·  GlaxoSmithKline (17)  ·  UCB Pharma (17)  ·  Chang Gung Memorial Hospital (16)  ·  VA Office of Research and Development (16)  ·  Avid Radiopharmaceuticals (15)  ·  M.D. Anderson Cancer Center (15)

Countries

United States (1543)  ·  France (253)  ·  Germany (251)  ·  Canada (240)  ·  United Kingdom (234)  ·  Spain (185)  ·  Italy (164)  ·  Australia (141)  ·  Netherlands (118)  ·  China (100)  ·  Poland (94)  ·  Japan (82)  ·  Belgium (80)  ·  Sweden (64)  ·  Austria (63)

Top investigators

Henry S. Friedman, MD (9)

Results publications

PMID 37870112, PMID 33175411, PMID 36602886, PMID 38588457, PMID 35305920, PMID 19775921, PMID 25918556, PMID 27657681, PMID 28403842, PMID 33974419, PMID 34532852, PMID 39800465, PMID 22163120, PMID 24144944, PMID 32593547, PMID 33189083, PMID 36463457, PMID 37059702, PMID 38114596, PMID 38706271, PMID 40368603, PMID 40680102, PMID 41114449, PMID 11112243, PMID 16135345, PMID 17175134, PMID 17941858, PMID 18296121, PMID 18662331, PMID 19453963, PMID 20548058, PMID 21484867, PMID 21586746, PMID 22474060, PMID 22520687, PMID 22738918, PMID 22961727, PMID 23176611, PMID 24001701, PMID 24144615, PMID 24524452, PMID 24711047, PMID 25098701, PMID 25378424, PMID 25677596, PMID 25726502, PMID 25731629, PMID 25744676, PMID 25988365, PMID 26603732

NIH funding

2014 (29), 2015 (21), 2009 (17), 2017 (17), 2018 (16), 2008 (15), 2016 (14), 2019 (12), 2023 (8), U01CA062399 (8), 2004 (7), 2005 (6), U10CA025224 (6), U10CA021661 (5), U01CA062475 (4)